Neuromyelitis optica spectrum disorders and beyond: telling a story one hundred years later
- PMID: 37379862
- PMCID: PMC10306988
- DOI: 10.1055/s-0043-1770932
Neuromyelitis optica spectrum disorders and beyond: telling a story one hundred years later
Conflict of interest statement
As of June 2023, Denis Bichuetti has received speaking/consulting honoraria and/or travel expenses to scientific meetings sponsored by Merck Serono, TEVA Pharmaceuticals, Biogen Idec, Bayer Health Care Pharma, Genzyme Sanofi Aventis, Novartis, Roche, Astra Zeneca, Pfizer, Horizon and Alexion.
References
-
- Gault F.De la Neuromyélite Optique Aigue Paris 1894 [Cópia digital da tese de Fernad Gault]. Available from:http://web2.bium.univ-paris5.fr/livanc/?cote=epo1112&do=pages
-
- Bichuetti D B, Oliveira E M, Souza N A, Rivero R L, Gabbai A A. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler. 2009;15(05):613–619. - PubMed
-
- Adoni T, Lino A M, da Gama P D. Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics. Mult Scler. 2010;16(01):81–86. - PubMed
-
- Alves-Leon S V, Pimentel M L, Sant'Anna G, Malfetano F R, Estrada C D, Quirico-Santos T.Immune system markers of neuroinflammation in patients with clinical diagnose of neuromyelitis optica Arq Neuropsiquiatr 200866(3B):678–684. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
